Amiloride handling in renal failure.
作者信息
George C F
出版信息
Br J Clin Pharmacol. 1980 Jan;9(1):94-5. doi: 10.1111/j.1365-2125.1980.tb04803.x.
Abstract
摘要
相似文献
1
Amiloride handling in renal failure.肾衰竭时氨氯吡咪的处理
Br J Clin Pharmacol. 1980 Jan;9(1):94-5. doi: 10.1111/j.1365-2125.1980.tb04803.x.
2
Kinetics and bioavailability of two formulations of amiloride in man.氨氯吡咪两种制剂在人体中的动力学和生物利用度
Br J Pharmacol. 1973 Aug;48(4):646-9.
3
Limitation on the use of amiloride in early renal failure.早期肾衰竭中使用氨氯吡咪的限制。
Eur J Clin Pharmacol. 1985;28(1):61-6. doi: 10.1007/BF00635709.
4
Kinetic analysis of the amiloride-sodium entry site interaction in rabbit colon.
Mol Pharmacol. 1981 Nov;20(3):543-50.
5
Pharmacokinetics of amiloride in renal and hepatic disease.
Eur J Clin Pharmacol. 1987;33(5):493-8. doi: 10.1007/BF00544242.
6
Renal tubule transport and electrolyte effects of amiloride in the chicken.氨氯地平对鸡肾小管转运及电解质的影响。
J Pharmacol Exp Ther. 1981 Nov;219(2):435-41.
7
[Renal uptake and intrarenal distribution of amiloride].[氨氯吡咪的肾脏摄取及肾内分布]
Res Exp Med (Berl). 1973 Jul 26;161(1):21-9. doi: 10.1007/BF01851019.
8
Apical membrane properties and amiloride binding kinetics of the human descending colon.
Am J Physiol. 1984 Dec;247(6 Pt 1):G749-57. doi: 10.1152/ajpgi.1984.247.6.G749.
9
Mechanism of potassium secretion in chronic renal failure studied by means of amiloride.应用氨氯吡咪研究慢性肾功能衰竭时钾分泌的机制。
Medicina (B Aires). 1981;41(4):431-8.
10
Amiloride as a probe for sodium entry sites in frog skin epithelium [proceedings].氨氯吡咪作为青蛙皮肤上皮钠进入位点的探针[会议论文集]
J Physiol. 1977 Mar;266(1):28P-29P.
引用本文的文献
1
Amiloride: biological fluid analysis by reverse-phase HPLC.阿米洛利：反相高效液相色谱法的生物流体分析。
Pharm Res. 1985 May;2(3):143-5. doi: 10.1023/A:1016371618594.
2
Limitation on the use of amiloride in early renal failure.早期肾衰竭中使用氨氯吡咪的限制。
Eur J Clin Pharmacol. 1985;28(1):61-6. doi: 10.1007/BF00635709.
3
Diuretics. Clinical pharmacology and therapeutic use (Part II).利尿剂。临床药理学与治疗应用（第二部分）。
Drugs. 1985 Feb;29(2):162-88. doi: 10.2165/00003495-198529020-00003.
4
A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients.
Eur J Clin Pharmacol. 1987;32(1):53-60. doi: 10.1007/BF00609957.
5
The elderly patient. A special case for diuretic therapy.老年患者。利尿治疗的特殊情况。
Drugs. 1986;31 Suppl 4:138-53. doi: 10.2165/00003495-198600314-00018.
6
Guide to drug dosage in renal failure.肾衰竭药物剂量指南。
Clin Pharmacokinet. 1988 Nov;15(5):326-54. doi: 10.2165/00003088-198815050-00005.
7
Amiloride disposition in geriatric patients: importance of renal function.老年患者中氨氯吡咪的处置：肾功能的重要性。
Br J Clin Pharmacol. 1990 Jan;29(1):1-8. doi: 10.1111/j.1365-2125.1990.tb03595.x.
8
Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.老年患者的抗高血压治疗。临床药代动力学考量。
Drugs Aging. 1991 May;1(3):194-211. doi: 10.2165/00002512-199101030-00004.
本文引用的文献
1
Clinical trial of a potassium-sparing saluretic pyrazine derivative (MK-870).一种保钾促尿剂吡嗪衍生物（MK - 870）的临床试验
Acta Med Scand. 1967 Apr;181(4):457-63. doi: 10.1111/j.0954-6820.1967.tb07264.x.
2
The meetabolism of amiloride hydroloride in man.盐酸阿米洛利在人体内的代谢。
Clin Pharmacol Ther. 1969 May-Jun;10(3):401-6. doi: 10.1002/cpt1969103401.
3
Pharmacological effects in animals and normal human subjects of the diuretic amiloride hydrochloride (MK-870).利尿药盐酸阿米洛利（MK - 870）对动物和正常人类受试者的药理作用。
Clin Pharmacol Ther. 1968 May-Jun;9(3):318-27. doi: 10.1002/cpt196893318.
4
Amiloride. A potassium-sparing natriuretic agent.氨氯吡咪。一种保钾利尿钠药。
Circulation. 1968 Jan;37(1):45-53. doi: 10.1161/01.cir.37.1.45.
5
Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870).
Metabolism. 1970 Jan;19(1):58-70. doi: 10.1016/0026-0495(70)90118-6.
6
MK 870: a new potassium-sparing diuretic.MK 870：一种新型保钾利尿剂。
N Z Med J. 1966 Aug;65(408):505-11.
7
Amiloride and plasma-potassium.氨氯吡咪与血钾
Lancet. 1968 Aug 31;2(7566):516-7. doi: 10.1016/s0140-6736(68)90679-x.
Zotero 插件